$461.4 Million Cushing's Syndrome Diagnostics and Treatment Market - Global Trajectory & Analytics, 2012-2019 & 2020-2027 - ResearchAndMarkets.com

The "Cushing's Syndrome Diagnostics and Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, September 25, 2020
Information
Tags: 
Health, Other Health, Adrenal gland disorders, Cushing's syndrome, RTT, Compound annual growth rate, Academic disciplines, Articles
Summary
Key Points: 
  • The "Cushing's Syndrome Diagnostics and Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Cushing's Syndrome Diagnostics and Treatment estimated at US$289.2 Million in the year 2020, is projected to reach a revised size of US$461.4 Million by 2027, growing at a CAGR of 6.9% over the period 2020-2027.
  • Diagnostics, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$187.2 Million by the end of the analysis period.
  • The U. S. Market is Estimated at $85.4 Million, While China is Forecast to Grow at 6.5% CAGR
    The Cushing's Syndrome Diagnostics and Treatment market in the U. S. is estimated at US$85.4 Million in the year 2020.


The "Cushing's Syndrome Diagnostics and Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Cushing's Syndrome Diagnostics and Treatment estimated at US$289.2 Million in the year 2020, is projected to reach a revised size of US$461.4 Million by 2027, growing at a CAGR of 6.9% over the period 2020-2027.

Diagnostics, one of the segments analyzed in the report, is projected to record 7.1% CAGR and reach US$187.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Treatment segment is readjusted to a revised 6.8% CAGR for the next 7-year period.

The U. S. Market is Estimated at $85.4 Million, While China is Forecast to Grow at 6.5% CAGR

The Cushing's Syndrome Diagnostics and Treatment market in the U. S. is estimated at US$85.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$80.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Corcept Therapeutics, Inc.
  • HRA Pharma
  • Novartis AG
  • Orphagen Pharmaceuticals, Inc.
  • Strongbridge Biopharma

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Cushing's Syndrome Diagnostics and Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/u74405

Copyright: 
Copyright Business Wire 2020